Articles related to RISK ASSESSMENT

A prospective study involving over 170,000 participants from the UK Biobank found that moderate coffee consumption (3 drinks/day) was associated with a 48.1% lower risk of developing cardiometabolic multimorbidity compared to non-consumers.

Recent research comparing SGLT2 inhibitors and dulaglutide in older patients with type 2 diabetes suggests a potential difference in dementia risk. The study estimated a risk ratio of 0.81 (CI, 0.56 to 1.16) for SGLT2 inhibitors compared to dulaglutide.

The PREVENT equation, developed by the American Heart Association in 2023, aims to provide a more accurate cardiovascular risk assessment for today’s population, potentially reducing statin prescriptions by 40%.

Prostate cancer screening guidelines that use race as a criterion are under ethical scrutiny, with experts calling for a shift towards universal, unbiased risk assessment that addresses socioeconomic factors and healthcare access disparities.

Infrequent soft stools were associated with higher risks of all-cause, cancer, and cardiovascular disease mortality, suggesting that stool monitoring could be a valuable indicator of major chronic illnesses.

Recent findings indicate that statin-naïve ACS patients with normal LDL-C levels at admission may face worse outcomes, challenging current perspectives on lipid management in cardiovascular care.